Skip to content

Stryker launches blood-flow diverter for brain aneurysms in the U.S.

August 24, 2020

Stryker (SYK -0.1%) has launched Surpass Evolve Flow Diverter, a 64-wire cobalt chromium flow diverter designed to re-direct blood flow and promote aneurysm healing.

Since its launch in Europe last year, Surpass Evolve has been approved in 45+ countries.

Mark Paul, president of Stryker’s Neurovascular division, added, “Surpass Evolve is our fourth PMA approval and second flow diverter approved by the FDA in the last two years.”

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: